AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia
Amgen
Amgen
Jonsson Comprehensive Cancer Center
University of Iowa
Fred Hutchinson Cancer Center